Not applicableUnknownNCT04674579What this trial is testingAutomatic Segmentation MRI Cerebral GliomaWho this might be right forCerebral Glioblastoma Assiut University 50
Early research (Phase 1)Ended earlyNCT00006773What this trial is testingBortezomib in Treating Patients With Recurrent GliomaWho this might be right forAdult Anaplastic AstrocytomaAdult Anaplastic OligodendrogliomaAdult Giant Cell Glioblastoma+3 more National Cancer Institute (NCI) 42
Testing effectiveness (Phase 2)Study completedNCT01268566What this trial is testingMEDI-575 in Subjects With Recurrent Glioblastoma MultiformeWho this might be right forGlioblastoma Multiforme MedImmune LLC 62
Large-scale testing (Phase 3)Looking for participantsNCT05303519What this trial is testingSIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)Who this might be right forGliomaAstrocytoma, Grade IVIDH1-mutant Glioma+5 more Nuvation Bio Inc. 365
Early research (Phase 1)Looking for participantsNCT04903795What this trial is testingBRiTE - Bispecific T Cell Engager for Patients With GlioblastomaWho this might be right forNewly Diagnosed GlioblastomaRecurrent Glioblastoma Mustafa Khasraw, MBChB, MD, FRCP, FRACP 18
Not applicableWithdrawnNCT04218019What this trial is testingEffect of Timing of Tumor-Treating Fields Plus Short-Course RadiationWho this might be right forNewly Diagnosed Glioblastoma in Patients ≥70 Years Juergen Debus
Testing effectiveness (Phase 2)Study completedNCT03463265What this trial is testingNab-sirolimus in Recurrent High Grade Glioma and Newly Diagnosed GlioblastomaWho this might be right forHigh Grade Recurrent Glioma and Newly Diagnosed Glioblastoma Aadi Bioscience, Inc. 62
Not applicableUnknownNCT05772741What this trial is testingGrafts of GSCs Into Brain Organoids for Testing Anti-invasion DrugsWho this might be right forGlioblastomaGlioma, Malignant Fondazione Policlinico Universitario Agostino Gemelli IRCCS 160
Testing effectiveness (Phase 2)Study completedNCT00107237What this trial is testingAEE788 and Everolimus in Treating Patients With Recurrent or Relapsed Glioblastoma MultiformeWho this might be right forBrain and Central Nervous System Tumors Novartis Pharmaceuticals 16
Testing effectiveness (Phase 2)Study completedNCT00597402What this trial is testingAvastin in Combination With Radiation (XRT) & Temozolomide, Followed by Avastin, Temozolomide and Irinotecan for Glioblastoma (GBM) and GliosarcomasWho this might be right forGlioblastomaGliosarcomaBrain Tumor Duke University 125
Early research (Phase 1)Temporarily pausedNCT06806228What this trial is testingPhase I Pilot Study to Evaluate the Anti-glioblastoma Effect of S-Gboxin in Standard Treatment of Glioblastoma/Diffuse Midline Glioma and Response to Treatment (Regardless of Mutation Status)Who this might be right forGlioblastoma MultiformeDiffuse Midline Glioma, H3 K27M-MutantGliosarcoma+2 more Petrov, Andrey 10
Testing effectiveness (Phase 2)Looking for participantsNCT05683808What this trial is testingVenous Thromboembolism Prevention in Outpatients With GliomaWho this might be right forGlioblastomaAstrocytomaVenous Thromboembolism University of Vermont Medical Center 40
Not applicableUnknownNCT00392548What this trial is testingURINARY VEGF Levels in GBM Patients on Radiation Treatment ProtocolWho this might be right forGlioblastoma Tel-Aviv Sourasky Medical Center 130
Not applicableStudy completedNCT05431348What this trial is testingEffect of stRess and exeRcize on the Outcome After Chemo-RadiationWho this might be right forGlioblastoma (GBM) Maastricht Radiation Oncology 42
Testing effectiveness (Phase 2)Active Not RecruitingNCT03688178What this trial is testingDC Migration Study to Evaluate TReg Depletion In GBM Patients With and Without VarlilumabWho this might be right forGlioblastoma Annick Desjardins, MD 43
Testing effectiveness (Phase 2)WithdrawnNCT02599090What this trial is testingPhase II Sorafenib With Radiation and Temozolomide in Newly Diagnosed Glioblastoma or GliosarcomaWho this might be right forGlioblastomaGliosarcoma M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00352313What this trial is testingATN-161 and Carboplatin in Treating Patients With Recurrent Malignant GliomaWho this might be right forBrain and Central Nervous System Tumors National Institutes of Health Clinical Center (CC) 82
Testing effectiveness (Phase 2)Study completedNCT00717197What this trial is testingStudy of Capecitabine to Treat Recurrent High Grade GliomasWho this might be right forMalignant Glioma University of Florida 30
Very early researchStudy completedNCT04937413What this trial is testingThe PCSK9i Inhibitor Evolocumab - a Surgical Trial of Pharamcodynamics and Kinetics EvaluationWho this might be right forMalignant GliomaGlioblastoma Duke University 32
Testing effectiveness (Phase 2)Study completedNCT00905060What this trial is testingHSPPC-96 Vaccine With Temozolomide in Patients With Newly Diagnosed GBMWho this might be right forBrain and Central Nervous System Tumors University of California, San Francisco 70